Chart: Biotech Stocks - Gross Profit Margins
-
Font Size:
Gross profit margins in the Biotech sector ranged from 100% ((ALXN), (NBIX), (INCY)) down to 35.0% (NABI), with the median for the group at 84.1%.
Data in table version -- click on a ticker for opinion and analysis of the company:
| Total | Gross | Gross | |||
|---|---|---|---|---|---|
| Quarter | Revenue | Profit | Profit | ||
| Ticker | Company | Ending | ($mm) | ($mm) | Margin (%) |
| AFFX | Affymetrix Inc. | 03/31/06 | $86.39 | $59.29 | 68.6%
|
| ALXN | Alexion Pharmaceuticals Inc. | 03/31/06 | $0.77 | $0.77 | 100.0%
|
| AMGN | Amgen Inc. | 03/31/06 | $3217.00 | $2665.00 | 82.8%
|
| AMLN | Amylin Pharmaceuticals Inc. | 03/31/06 | $82.35 | $72.60 | 88.2%
|
| BIIB | Biogen Idec Inc. | 03/31/06 | $611.18 | $547.68 | 89.6%
|
| BMRN | BioMarin Pharmaceutical Inc. | 12/31/05 | $9.48 | $9.25 | 97.6%
|
| BSTE | Biosite Incorporated | 03/31/06 | $79.33 | $56.23 | 70.9%
|
| CELG | Celgene Corporation | 03/31/06 | $181.84 | $151.70 | 83.4%
|
| DNA | Genentech Inc. | 03/31/06 | $1986.00 | $1724.00 | 86.8%
|
| ELN | Elan Corp. plc | 03/31/06 | $134.30 | $86.50 | 64.4%
|
| GILD | Gilead Sciences Inc. | 03/31/06 | $692.88 | $609.32 | 87.9%
|
| GPRO | Gen-Probe Inc. | 03/31/06 | $86.26 | $60.28 | 69.9%
|
| IMCL | Imclone Systems Inc. | 03/31/06 | $245.13 | $194.58 | 79.4%
|
| INCY | Incyte Corp. | 12/31/05 | $1.03 | $1.03 | 100.0%
|
| ISTA | ISTA Pharmaceuticals Inc. | 12/31/05 | $3.68 | $2.45 | 66.6%
|
| KOSP | KOS Pharmaceuticals Inc. | 12/31/05 | $213.92 | $187.18 | 87.5%
|
| MEDI | MedImmune Inc. | 03/31/06 | $498.00 | $374.90 | 75.3%
|
| NABI | Nabi Biopharmaceuticals | 04/01/06 | $27.55 | $11.94 | 43.3%
|
| NBIX | Neurocrine Biosciences Inc. | 03/31/06 | $19.48 | $19.48 | 100.0%
|
| ONXX | Onyx Pharmaceuticals Inc. | 12/31/05 | N/A | $0.00 | N/A
|
| PGNX | Progenics Pharmaceuticals Inc. | 12/31/05 | $2.05 | -$18.37 | N/A
|
| PHRM | Pharmion Corp. | 03/31/06 | $56.59 | $41.38 | 73.1%
|
| TELK | Telik Inc. | 12/31/05 | N/A | $0.00 | N/A
|
| VRTX | Vertex Pharmaceuticals Inc. | 03/31/06 | $39.09 | $36.09 | 92.3% |
Data: Capital IQ
Related:
- Most recent opinion and analysis of Biotech stocks
- Full transcripts of recent conference calls in the Biotech sector
- Add the Biotech Stock Blog to your My Yahoo! page
Aside: Did you know that Seeking Alpha now publishes a daily recap of Jim Cramer's Mad Money stock picks?
Get Seeking Alpha Free Stock Alerts by Email!
Get Free Stock Alerts by Email!
Loading...
Symbols:
-
Editor's Picks
-
Most Popular
- American Express Calls Investment Banks' Bluff
- Japan: Recession-Bound As Exports Slow?
- iShares MSCI Mexico: Surprising Strength South of the Border
- A Fed Rate Hike Won't Solve the Current Crisis
- Understanding Metastorm's IPO as an Investment Opportunity
- Mr. Cuomo, ARS Investors Don't Need a Spitzeresque Settlement
- Full list of Editor's Picks »
- Three Stocks To Be Held To Infinity and Beyond »
- As WaMu, Wachovia Ready Earnings, Comparisons to Wells, USB Are Telling »
- Wall Street Breakfast: Must-Know News »
- Steve Jobs' Health: A Red Herring »
- Financials: How - And When - We Reached the Bottom »
- Four Long-Term Winners Selling at Deep Discounts »
- Apple F3Q08 (Qtr End 6/28/08) Earnings Call Transcript »
- Earnings Preview: Washington Mutual »
- The Agriculture Boom Goes Bust »
- Crazy Dividends »
- Apple's a Buy Under $150 »
-
Long Ideas
-
Short Ideas
-
Cramer's Picks
- Auto Retailers' Ability to Pay Debt - What It Means
- Three Conservative Growth Industrial Picks: Adminstaff, Carlisle Companies and Illinois Tool Works
- Wait for August FFIEC Call Reports Before Taking a Long Position in Banks
- Now's the Time to Buy Something
- 3Com Corp.: Undervalued by Half
- Wachovia CEO's Insider Buying Is Another Indication of a Bottom
- Consumer Staple Stocks Are Not Always Safe Haven Investments
- The Long Case for Abbott Laboratories
- AT&T Stays Ahead of the Curve in a Dynamic Industry
- Dollar Back? - Fast Money Recap (7/23/08)
- Full list of Long Ideas »
- Collateral Damage From the War on Shorts
- Is the Gold Uptrend Over?
- Response to Raymond James' Q3 Conference Call
- eBay is a Not Com - Cramer's Lightning Round (7/23/08)
- Get True Religion - Cramer's Lightning Round (7/22/08)
- Principal Financial Group Vulnerable to Commercial Real Estate Softening?
- Increases in Shorting, Only for Some
- Is a Ban on Short Financial ETFs on the Horizon?
- Is There a More Efficient Shorting Tactic?
- Short Oil as a Long Investment
- Full list of Short Ideas »
- eBay is a Not Com - Cramer's Lightning Round (7/23/08)
- Buy Costco, Get Sirius - Cramer's Stop Trading! (7/23/08)
- Soup Target; Cramer's Mad Money (7/22/08)
- Get True Religion - Cramer's Lightning Round (7/22/08)
- Copper Down Low - Cramer's Stop Trading! (7/22/08)
- Banks Hit Bottom – Cramer’s Mad Money (7/21/08)
- Ends In X - Cramer's Stop Trading! (7/21/08)
- Great American Companies – Cramer’s Lightning Round (7/21/08)
- Market Rotation Bolsters Financials - Fast Money Recap (7/18/08)
- For Everything, Wind - Stop Trading! (7/17/08)
- Full list of Cramers Picks »
Most Popular Feeds
-
ETFs
-
US Market
-
Long Ideas
-
Alt. Energy
- Full list of feeds »
Hedge Fund Jobs
Job Seekers:
- Search jobs by category
- Get job alerts by email or live feed
- Apply online
Employers
- See all recruitment options
- Get applications online or by email


